Or Filter by:

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

10-JAN-2020

Elanco Announces 2020 Financial Guidance

Post by: Colleen Parr Dekker

  • 2020 revenue is expected to be between $3.05 billion and $3.11 billion.
  • Earnings per share (EPS) for 2020 are expected to be in the range of $0.04 to $0.16 on a reported basis and $1.09 to $1.16 on an adjusted basis.
  • China regulatory clearance received for acquisition of Bayer AG’s animal health business. Additional antitrust discussions progressing as expected.

Media Contact:
Colleen Parr Dekker
(317) 989-7011
colleen_parr_dekker@elanco.com

Investors Contact:
Jim Greffet
(317) 383-9935
greffet_james_f@elanco.com

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

About Elanco

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.